Today: 5 April 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead Sciences shares rose 3.5% to $135.73 Friday, hitting new highs after Phase 3 trial data showed its Trodelvy-Keytruda combo cut the risk of disease progression or death by 35% in metastatic triple-negative breast cancer. Gilead has filed for expanded approval in the U.S. and Europe. Volume reached 8.8 million shares. A Form 144 filing showed executive Deborah Telman plans to sell up to 29,215 shares.
23 January 2026
·····
FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation stock drops in New York trade as investors weigh CFM56 pact and fresh BTIG target hike

FTAI Aviation shares fell 1.2% to $289.86 Friday afternoon, following the announcement of a multi-year CFM56 engine support deal with CFM International. The agreement gives FTAI direct access to OEM parts and repairs. Analyst Andre Madrid raised his price target to $335, citing the deal’s strategic value. FTAI will report Q4 and full-year results on Feb. 25.
23 January 2026
··
Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue (KVUE) stock price barely budges as Kimberly-Clark deal vote nears

Kenvue shares rose 0.1% to $17.77 Friday as investors await a Jan. 29 shareholder vote on its proposed sale to Kimberly-Clark. The deal would give Kenvue holders $3.50 in cash and 0.14625 Kimberly-Clark shares per Kenvue share. Institutional Shareholder Services recommended approval but cited litigation risks. Trading volume has surged ahead of the vote.
23 January 2026
···
Amphenol stock slips as Wall Street waits for earnings next week

Amphenol stock slips as Wall Street waits for earnings next week

Amphenol shares fell about 0.9% to $151.14 Friday afternoon as investors awaited its quarterly report due January 28. Trading volume was below average, with focus on the integration of the recently acquired CommScope connectivity business. The company expects the deal to boost adjusted profits by 2026. Broader U.S. markets were mixed, with the Dow down and S&P 500 near flat.
23 January 2026
··
PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC stock price slips as regional banks slide — bond sale and Fed week loom

PNC shares fell 1.4% to $218.91 by Friday afternoon, tracking a broader 3% drop in regional bank stocks. A filing showed PNC plans to raise $1.5 billion in subordinated notes due 2041 and $1.5 billion in senior notes due 2029. Investors are watching next week’s Federal Reserve meeting and bank guidance on net interest income. First Citizens BancShares shares dropped 8% after warning of weaker net interest income for 2026.
23 January 2026
··
USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

USB stock falls today as bank sector slides; U.S. Bancorp bond sale and Fed week in focus

U.S. Bancorp shares fell 1.1% to $55.58 Friday afternoon, tracking a 3% drop in the SPDR S&P Bank ETF as regional banks slid after First Citizens BancShares’ weak outlook. The lender priced $2.25 billion in fixed-to-floating senior notes this week. Investors are focused on next week’s Federal Reserve meeting and its impact on bank margins. Wells Fargo, Bank of America, and JPMorgan also declined in afternoon trading.
23 January 2026
····
Accenture stock slides in New York: traders weigh Sovereign AI deal and fresh Buy call

Accenture stock slides in New York: traders weigh Sovereign AI deal and fresh Buy call

Accenture shares fell 1.2% to $281.73 by midafternoon Friday, despite recent announcements of a major AI data center partnership with Sovereign AI and Palantir across EMEA. Berenberg initiated coverage with a buy rating and a $313 target. Investors remain uncertain about the timing of revenue from new AI projects. Accenture’s next earnings call is scheduled for March 19.
23 January 2026
·········
Gold races toward $5,000 as Ray Dalio warns of ‘capital wars’ and dollar strain

Gold races toward $5,000 as Ray Dalio warns of ‘capital wars’ and dollar strain

Gold hit a record $4,993.02 an ounce Friday, silver topped $100, as investors sought safe havens amid geopolitical tensions and a weaker dollar. Ray Dalio warned at Davos that the old “rule-based” order is gone, raising the risk of “capital wars.” Asset managers promoted gold and bitcoin as hedges against inflation and currency debasement. The dollar index fell 1.65% this week after tariff threats over Greenland.
23 January 2026
Silver breaks $100 as gold nears $5,000 — what’s driving the record precious-metals run

Silver breaks $100 as gold nears $5,000 — what’s driving the record precious-metals run

Spot silver jumped above $100 an ounce for the first time, closing at $100.94 late Friday. Gold neared $5,000, hitting a session high of $4,988.17, as investors sought safe havens amid geopolitical tensions and rate cut expectations. Platinum and palladium also surged, with platinum reaching a record $2,771.10. Tight supply and thin liquidity fueled sharp price swings across metals markets.
23 January 2026
Palo Alto Networks (PANW) stock slips while cyber peers climb as AI security talk heats up

Palo Alto Networks (PANW) stock slips while cyber peers climb as AI security talk heats up

Palo Alto Networks shares fell 1% to $180.46 Friday, underperforming tech peers after launching new AI-driven security products. Most cybersecurity stocks rose, with Fortinet up over 5%. The company this week announced updates to its Hybrid Mesh Firewall and a new Prisma Browser Connector. Investors await Palo Alto’s next earnings report amid concerns over security spending and growth forecasts.
23 January 2026
···
Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer stock slips on ex-dividend day — what to watch ahead of Feb. 3 earnings

Pfizer shares fell 1.9% to $25.62 Friday as the stock went ex-dividend, nearly matching the $0.43 payout. The drop outpaced the health-care sector, with Moderna tumbling over 7% and Merck down 1%. Policy changes under Health Secretary Robert F. Kennedy Jr. have unsettled vaccine makers. Pfizer reports quarterly results and hosts a webcast on Feb. 3.
23 January 2026
·····
1 … 257 258 259 260 261 … 732

Stock Market Today

  • Lassonde Industries (TSX:LAS.A) Undervalued Amid Recent Pullback and Long-Term Gains
    April 4, 2026, 8:13 PM EDT. Lassonde Industries (TSX:LAS.A) shares fell 1.8% recently after modest short-term gains but show strong long-term returns, including a 147.81% rise over three years. Trading at CA$232.79, the stock is approximately 67% below its estimated intrinsic value of CA$270.75, supported by analysts' consensus price target. This valuation assumes revenue growth to CA$3.3 billion and earnings of CA$197 million by 2029, with a price-earnings (PE) ratio of 11.2x and a 6.3% discount rate. Key risks include potential declines in juice category volumes and rising input costs, especially fruit concentrates, which could affect margins. Investors are advised to weigh these risks against long-term growth prospects before making decisions, using tools like founder-led company screeners for broader market comparisons.
Go toTop